These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6374800)

  • 1. Currently active protocols in the EORTC Breast Cancer Cooperative Group.
    Mouridsen HT; Palshof T; Mattheiem W; Sylvester RJ; Rotmensz N; Paridaens RJ
    Recent Results Cancer Res; 1984; 91():263-7. PubMed ID: 6374800
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant systemic therapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group's trials of cyclophosphamide or CMF in premenopausal and tamoxifen in postmenopausal patients.
    Mouridsen HT; Rose C; Brincker H; Thorpe SM; Rank F; Fischerman K; Andersen KW
    Recent Results Cancer Res; 1984; 96():117-28. PubMed ID: 6396765
    [No Abstract]   [Full Text] [Related]  

  • 3. Tamoxifen and combination chemotherapy as adjuvant treatment in postmenopausal women with breast cancer.
    Wallgren A; Baral E; Beling U; Carstensen J; Friberg S; Glas U; Kaigas M; Skoog L
    Recent Results Cancer Res; 1984; 96():197-203. PubMed ID: 6396775
    [No Abstract]   [Full Text] [Related]  

  • 4. Ludwig Breast Cancer trial LBCS III: chemo- and endocrine adjuvant treatment in postmenopausal patients.
    Gelber RD
    Recent Results Cancer Res; 1984; 96():102-9. PubMed ID: 6396763
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant systemic therapy in primary breast cancer.
    Mouridsen HT; Palshof T
    Acta Chir Scand Suppl; 1984; 519():43-53. PubMed ID: 6393664
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of advanced breast cancer with aminoglutethimide--response after previous tamoxifen treatment.
    Bezwoda WR; Derman DP; Browde S; Goss G; Lange M
    S Afr Med J; 1984 Sep; 66(10):372-4. PubMed ID: 6484759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoendocrine versus endocrine therapy in breast cancer.
    Alessandroni M; Silber JH
    Lancet; 1984 Oct; 2(8408):922-3. PubMed ID: 6148637
    [No Abstract]   [Full Text] [Related]  

  • 8. Endocrine factors in the outcome of systemic adjuvant therapy of early breast cancer.
    Bianco AR; De Placido S; Perrone F; Carlomagno C; De Laurentiis M; Del Mastro L; Lauria R; Marinelli A; Gallo C
    Ann N Y Acad Sci; 1993 Nov; 698():330-8. PubMed ID: 8279772
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant chemo- and endocrine therapy alone or in combination in premenopausal patients (GABG Trial 1).
    Kaufmann M; Jonat W; Abel U
    Recent Results Cancer Res; 1989; 115():118-25. PubMed ID: 2696024
    [No Abstract]   [Full Text] [Related]  

  • 10. Preoperative (neoadjuvant) chemotherapy for breast cancer: outline of the British Columbia Trial.
    Ragaz J
    Recent Results Cancer Res; 1986; 103():85-94. PubMed ID: 3526477
    [No Abstract]   [Full Text] [Related]  

  • 11. Ludwig Breast Cancer trials LBCS III and IV: adjuvant endocrine treatment in postmenopausal patients.
    Goldhirsch A
    Recent Results Cancer Res; 1984; 96():204-9. PubMed ID: 6549355
    [No Abstract]   [Full Text] [Related]  

  • 12. Postmenopausal node-positive comparison of observation with CMFP and CMPF + tamoxifen adjuvant therapy: an Eastern Cooperative Oncology Group trial.
    Tormey DC; Taylor SG; Gray R; Olson JE
    Recent Results Cancer Res; 1984; 96():110-6. PubMed ID: 6396764
    [No Abstract]   [Full Text] [Related]  

  • 13. Salvage treatments in relapsing resectable breast cancer.
    Valagussa P; Brambilla C; Zambetti M; Bonadonna G
    Recent Results Cancer Res; 1989; 115():69-76. PubMed ID: 2696043
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination chemotherapy compared to tamoxifen as initial therapy for stage IV breast cancer in elderly women.
    Taylor SG; Gelman RS; Falkson G; Cummings FJ
    Ann Intern Med; 1986 Apr; 104(4):455-61. PubMed ID: 3513684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
    Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
    Cancer; 1982 Dec; 50(11):2265-8. PubMed ID: 6754061
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between estrogen receptors and CMF adjuvant chemotherapy.
    Bonadonna G; Di Fronzo G; Tancini G; Brambilla C; Rossi A; Marchini S; Valagussa P
    Recent Results Cancer Res; 1984; 91():205-9. PubMed ID: 6547243
    [No Abstract]   [Full Text] [Related]  

  • 17. The medical management of breast cancer.
    Costanza ME
    Clin Obstet Gynecol; 1982 Jun; 25(2):433-41. PubMed ID: 7105517
    [No Abstract]   [Full Text] [Related]  

  • 18. Scottish adjuvant breast cancer trials: results in pre-menopausal patients.
    Stewart HJ
    Recent Results Cancer Res; 1989; 115():126-31. PubMed ID: 2696025
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group.
    Boccardo F; Rubagotti A; Bruzzi P; Cappellini M; Isola G; Nenci I; Piffanelli A; Scanni A; Sismondi P; Santi L
    J Clin Oncol; 1990 Aug; 8(8):1310-20. PubMed ID: 2199618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.
    Taylor SG; Kalish LA; Olson JE; Cummings F; Bennett JM; Falkson G; Tormey DC; Carbone PP
    J Clin Oncol; 1985 Feb; 3(2):144-54. PubMed ID: 3881561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.